Replay available

Neuronetics, Inc. (STIM) Q4 2025 Earnings Call

Neuronetics, Inc. (NASDAQ: STIM) Q4 2025 earnings conference call, held 2026-03-17. Replay captured from the company's public earnings webcast.

Tue, March 17, 2026 at 8:30 AMendedReplay
Neuronetics, Inc. (STIM) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Danny Stauder

Equity Research Analyst at Citizens

Bill Plovonik

Equity Research Analyst at Canaccord

Keith Sullivan

President and Chief Executive Officer

Adam Mader

Equity Research Analyst at Piper Sandler

Steve Fansfield

Chief Financial Officer

Mark Klausner

Investor Relations

Corey Anderson

Chief Technology Officer

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by and welcome to the Neuronetics Report's fourth quarter 2025 financial and operating results. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. And to ask a question during this session, you would need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to turn the conference over to Mark Klausner. Sir, please go ahead. Good morning, and thank you for joining us for the Neuronetics fourth quarter 2025 conference call. Joining me on today's call are Neuronetics President and Chief Executive Officer Keith Sullivan and Steve Fansfield, Neuronetics Chief Financial Officer. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to our business, strategy, financial and revenue guidance, the Greenbrook integration, and other operational issues and metrics. Actual results can differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. For a discussion of risks and uncertainties associated with Neuronetic's business, I encourage you to review the company's filings with the Securities and Exchange Commission, including the company's annual report on Form 10-K, which was filed premarket today. The company disclaims any obligation to up...

More from Neuronetics, Inc.